Published in

Springer, Journal of Neurology, 2(269), p. 933-944, 2021

DOI: 10.1007/s00415-021-10676-6

Links

Tools

Export citation

Search in Google Scholar

PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study

Journal article published in 2022 by Clara G. Chisari, Giancarlo Comi, Massimo Filippi, Damiano Paolicelli, Brescia Morra, Pietro Iaffaldano, Mauro Zaffaroni, Vincenzo Brescia Morra, Eleonora Cocco, Girolama Alessandra Marfia, Luigi Maria Grimaldi, Matilde Inglese ORCID, Simona Bonavita, Alessandra Lugaresi ORCID, Giuseppe Salemi and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO